The BETA-Protect Collaboration

The mission of the BETA-Protect collaboration is to eliminate rejection as a barrier to using regenerative cellular therapies for the treatment of type I diabetes. It provides unrivalled expertise and infrastructure to definitively determine how the immune system recognises cellular therapies for type I diabetes and to optimise strategies to prevent their rejection.